Loading clinical trials...
Loading clinical trials...
This is a multi-center, blinded study to determine the performance of the YD Diagnostic Corporation (YD) REBA MTB-MDR® and Hain Genotype MTBDRplus V2 kit in a total of 600 clinical isolates and 900 re...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Foundation for Innovative New Diagnostics, Switzerland
Collaborators
NCT04260477 · Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, and more
NCT05081401 · Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, and more
NCT07393438 · Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis, and more
NCT05017324 · Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, and more
NCT01521364 · Multidrug-resistant Tuberculosis, Extensively Drug-resistant Tuberculosis
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions